BC-05 is an orally active and potent inhibitor of CD13 and proteasome . BC-05 has an IC 50 value of 0.13 μM for human CD13 and an IC 50 value of 1.39 μM for the 20S proteasome . BC-05 can be used in multiple myeloma research.
Products | Products > Disease Areas > Cancer | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Research Areas > Cancer | Products > Research Areas > Cancer > Cancer Targeted Therapy | Products > Research Areas > Cancer > Cancer Metabolism and Metastasis | Products > Signaling Pathways > Proteasome
Please leave a message for us or use the following ways to contact us, we will reply to you as soon as possible, and provide you with the most sincere service, thank you.